ESC 365
Menu
Home
Search
Live & Upcoming Events
About
Create an account
Sign in
Back
HFA Premium Access
The hyperkalaemia challenge in heart failure: what is the role of novel agents?
Event:
Heart Failure 2019 - 6th World Congress on Acute Heart Failure
Topic:
Treatment
Session type:
Satellite Symposium
Sponsored by AstraZeneca
Date:
25 May 2019
Time:
13:30 - 14:30
Session
0
5
presentations
in this session
Chair's introduction - The hyperkalaemia challenge in heart failure: what is the role of novel agents?
Speaker:
Professor A. Coats (Coventry, GB)
Access
0
What is the clinical impact of hyperkalaemia?
Speaker:
Professor C. Linde (Stockholm, SE)
Access
0
Hyperkalaemia: a barrier to optimal management of patients with heart failure?
Speaker:
Professor A. Coats (Coventry, GB)
Access
0
Solving the K+ challenge in heart failure: are novel K+ binders the answer?
Speaker:
Professor M. Volterrani (Rome, IT)
Access
0
Clinical experience with novel K+ binders: what are the opportunities and challenges?
Speaker:
Professor C. Linde (Stockholm, SE)
Speaker:
Professor A. Coats (Coventry, GB)
Speaker:
Professor M. Volterrani (Rome, IT)
Access
0
7
speakers
from this session
Professor Andrew Coats
University of Warwick, Coventry (United Kingdom of Great Britain & Northern Ireland)
88
presentations
4
followers
Professor Cecilia Linde
Karolinska Institutet, Stockholm (Sweden)
42
presentations
1
follower
Professor Andrew Coats
University of Warwick, Coventry (United Kingdom of Great Britain & Northern Ireland)
88
presentations
4
followers
Professor Maurizio Volterrani
IRCCS San Raffaele Pisana, Rome (Italy)
15
presentations
0
follower
Professor Cecilia Linde
Karolinska Institutet, Stockholm (Sweden)
42
presentations
1
follower
Professor Andrew Coats
University of Warwick, Coventry (United Kingdom of Great Britain & Northern Ireland)
88
presentations
4
followers
Professor Maurizio Volterrani
IRCCS San Raffaele Pisana, Rome (Italy)
15
presentations
0
follower
This platform is supported by